biotech · SCNI
Scinai Immunotherapeutics
Scinai Immunotherapeutics drug portfolio — 0 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
JERUSALEM, L3, USA HQ
Public company Type
SCNI · NYSE Ticker
Company details
- Status
- Public
- HQ
- JERUSALEM, L3, USA
- Programs
- 0
- Drugs
- 0
- Patents
- 0
Scinai Immunotherapeutics pipeline
Portfolio lens on 0 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Scinai Immunotherapeutics drug portfolio — 0 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.